Skip to main content
TipRanks
Go Ultimate75% OFF

Shine-On Biomedical Co., Ltd. (6926) Financial Statements

Shine-On Biomedical Co., Ltd. Financial Overview

Shine-On Biomedical Co., Ltd.'s market cap is currently NT$2.99B. The company's EPS TTM is NT$-3.65; its P/E ratio is -16.44; Shine-On Biomedical Co., Ltd. has not announced its next earnings date. See an overview of income statement, balance sheet, and cash flow financials.

Financial overview
Dec 25Dec 24Dec 23Dec 22Dec 21
Income Statement
Total RevenueNT$ 30.00MNT$ 0.00NT$ 9.52MNT$ 0.00NT$ 0.00
Gross ProfitNT$ 27.93MNT$ -2.19MNT$ 6.67MNT$ -1.63MNT$ -638.00K
Operating IncomeNT$ -125.50MNT$ -136.07MNT$ -62.68MNT$ -21.79MNT$ -8.62M
EBITDANT$ -123.43MNT$ -116.37MNT$ -33.01MNT$ -20.17MNT$ -7.78M
Net IncomeNT$ -110.28MNT$ -118.89MNT$ -37.16MNT$ -19.54MNT$ -8.43M
Balance Sheet
Cash & Short-Term InvestmentsNT$ 922.17MNT$ 1.04BNT$ 1.14BNT$ 1.17BNT$ 905.98M
Total AssetsNT$ 950.94MNT$ 1.06BNT$ 1.16BNT$ 1.18BNT$ 911.82M
Total DebtNT$ 1.36MNT$ 2.60MNT$ 538.00KNT$ 1.52MNT$ 2.67M
Net DebtNT$ -47.81MNT$ -42.06MNT$ -101.49MNT$ -371.64MNT$ -822.32M
Total LiabilitiesNT$ 43.66MNT$ 42.21MNT$ 23.25MNT$ 4.14MNT$ 4.25M
Stockholders' EquityNT$ 907.28MNT$ 1.02BNT$ 1.14BNT$ 1.17BNT$ 907.57M
Cash Flow
Free Cash FlowNT$ -115.78MNT$ -92.06MNT$ -27.54MNT$ -24.43MNT$ -9.30M
Operating Cash FlowNT$ -114.75MNT$ -91.45MNT$ -26.88MNT$ -21.66MNT$ -6.34M
Investing Cash FlowNT$ 120.53MNT$ 35.36MNT$ -243.26MNT$ -714.78MNT$ -84.24M
Financing Cash FlowNT$ -1.27MNT$ -1.28MNT$ -991.00KNT$ 284.61MNT$ 915.57M

Currency in TWD

Shine-On Biomedical Co., Ltd. Earnings and Revenue History

-160M-80M080M-396 %-384 %-372 %-360 %EarningsProfit Margin20212022202320242025RevenueEarningsProfit Margin

Shine-On Biomedical Co., Ltd. Liabilities to Assets

0500M1B1.5B0 %2 %4 %6 %LiabilitiesLiabilities to Assets20212022202320242025AssetsLiabilitiesLiabilities to Assets

Shine-On Biomedical Co., Ltd. Cash Flow

-1B-500M0500M1B20212022202320242025OperatingInvestingFinancing

Shine-On Biomedical Co., Ltd. Forecast EPS vs Actual EPS